纳武单抗诱发晚期黑色素瘤患者肝窦阻塞综合征：一例报告 - Suppr | 超能文献

相似文献

1

Hepatic sinusoidal obstruction syndrome induced by nivolumab in advanced melanoma: a case report.纳武单抗诱发晚期黑色素瘤患者肝窦阻塞综合征：一例报告

Ann Oncol. 2020 May;31(5):661-662. doi: 10.1016/j.annonc.2020.02.004. Epub 2020 Feb 20.

2

Hepatic sinusoidal obstruction syndrome associated with nivolumab: an uncommon adverse event related to immune checkpoint inhibitors.与纳武单抗相关的肝窦阻塞综合征：一种与免疫检查点抑制剂相关的罕见不良事件。

J Gastrointestin Liver Dis. 2021 Mar 13;30(1):171-172. doi: 10.15403/jgld-3207.

3

Hepatic sinusoidal obstruction syndrome after immune-checkpoint-inhibitor therapy: when the liver sends SOS.免疫检查点抑制剂治疗后的肝窦阻塞综合征：当肝脏发出 SOS 信号。

BMJ Case Rep. 2024 Sep 30;17(9):e260066. doi: 10.1136/bcr-2024-260066.

4

Pharmacogenetics of gemtuzumab-associated hepatic sinusoidal occlusion syndrome after hematopoietic stem cell transplant.

Acta Haematol. 2003;110(4):207-10. doi: 10.1159/000074229.

5

SOS! Immunotherapy-Associated Sinusoidal Obstructive Syndrome.紧急求救！免疫疗法相关的窦性阻塞综合征。

J Oncol Pract. 2019 Dec;15(12):675-676. doi: 10.1200/JOP.19.00276. Epub 2019 Oct 16.

6

Azathioprine-induced hepatic sinusoidal obstruction syndrome.硫唑嘌呤诱导的肝窦阻塞综合征。

Med Clin (Barc). 2018 Aug 10;151(3):127-128. doi: 10.1016/j.medcli.2017.12.012. Epub 2018 Feb 26.

7

Hepatic veno-occlusive disease related to Gynura segetum: A case report.与白凤菜相关的肝静脉闭塞病：一例报告。

Medicine (Baltimore). 2018 Apr;97(17):e0552. doi: 10.1097/MD.0000000000010552.

8

Gemtuzumab ozogamicin (MylotargTM) is infrequently associated with sinusoidal obstructive syndrome/veno-occlusive disease.吉妥珠单抗奥唑米星（麦罗塔TM）与窦性阻塞综合征/静脉闭塞性疾病的关联并不常见。

Ann Oncol. 2004 Aug;15(8):1231-6. doi: 10.1093/annonc/mdh324.

9

Magnetic Resonance Imaging Findings in Patients With Pyrrolizidine Alkaloid-Induced Hepatic Sinusoidal Obstruction Syndrome.吡咯里西啶生物碱所致肝窦阻塞综合征患者的磁共振成像表现

Clin Gastroenterol Hepatol. 2017 Jun;15(6):955-957. doi: 10.1016/j.cgh.2017.01.009. Epub 2017 Jan 23.

10

Probable veno-occlusive disease after treatment with gemtuzumab ozogamicin in a patient with acute myeloid leukemia and a history of liver transplantation for familial hemochromatosis.

Med Oncol. 2003;20(4):379-84. doi: 10.1385/MO:20:4:379.

引用本文的文献

1

Drug-induced sinusoidal obstruction syndrome: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System (FEARS).药物性窦性阻塞综合征：一项基于美国食品药品监督管理局不良事件报告系统（FEARS）的真实世界药物警戒研究。

BMC Pharmacol Toxicol. 2025 Jul 18;26(1):135. doi: 10.1186/s40360-025-00965-5.

2

Immune-Mediated Liver Injury From Checkpoint Inhibitor: An Evolving Frontier With Emerging Challenges.免疫检查点抑制剂介导的肝损伤：一个充满新挑战的前沿领域。

Liver Int. 2025 Feb;45(2):e16198. doi: 10.1111/liv.16198.

3

Drug-induced hepatic sinusoidal obstruction syndrome: current advances and future perspectives.